SEC Info - Cit Group Inc - ‘10-Q’ for 3/31/18

SEC Info℠

Home

Help

Please Sign In

Cit Group Inc – ‘10-Q’ for 3/31/18 – ‘EX-101.SCH’

On: Friday, 5/4/18, at 4:34pm ET · For: 3/31/18 · Accession #: 1628280-18-5979 · File #: 1-31369

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/04/18  Cit Group Inc                     10-Q        3/31/18  112:25M                                    Workiva Inc Wde… FA01/FA

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.13M 
 2: EX-10.23    Material Contract                                   HTML    170K 
 3: EX-10.24    Material Contract                                   HTML    111K 
 4: EX-12.1     Statement re: Computation of Ratios                 HTML     43K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     38K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     38K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     34K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     34K 
15: R1          Document and Entity Information                     HTML     51K 
16: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    128K 
17: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     66K 
                (Parenthetical)                                                  
18: R4          Condensed Consolidated Statements of Income         HTML    139K 
                (Unaudited)                                                      
19: R5          Condensed Consolidated Statements of Comprehensive  HTML     52K 
                Income (Unaudited)                                               
20: R6          Condensed Consolidated Statements of Stockholders'  HTML     67K 
                Equity (Unaudited)                                               
21: R7          Condensed Consolidated Statements of Cash Flows     HTML    138K 
                (Unaudited)                                                      
22: R8          Business and Summary of Significant Accounting      HTML     87K 
                Policies                                                         
23: R9          Discontinued Operations                             HTML    155K 
24: R10         Loans                                               HTML    656K 
25: R11         Allowance For Loan Losses                           HTML    119K 
26: R12         Investment Securities                               HTML    275K 
27: R13         Borrowings                                          HTML    165K 
28: R14         Derivative Financial Instruments                    HTML    215K 
29: R15         Fair Value                                          HTML    475K 
30: R16         Stockholders' Equity                                HTML    161K 
31: R17         Regulatory Capital                                  HTML     94K 
32: R18         Income Taxes                                        HTML     43K 
33: R19         Commitments                                         HTML     91K 
34: R20         Contingencies                                       HTML     47K 
35: R21         Business Segment Information                        HTML    139K 
36: R22         Subsequent Events                                   HTML     37K 
37: R23         Business and Summary of Significant Accounting      HTML    104K 
                Policies (Policies)                                              
38: R24         Business and Summary of Significant Accounting      HTML     51K 
                Policies (Tables)                                                
39: R25         Discontinued Operations (Tables)                    HTML    154K 
40: R26         Loans (Tables)                                      HTML    641K 
41: R27         Allowance For Loan Losses (Tables)                  HTML    119K 
42: R28         Investment Securities (Tables)                      HTML    278K 
43: R29         Borrowings (Tables)                                 HTML    155K 
44: R30         Derivative Financial Instruments (Tables)           HTML    266K 
45: R31         Fair Value (Tables)                                 HTML    438K 
46: R32         Stockholders' Equity (Tables)                       HTML    158K 
47: R33         Regulatory Capital (Tables)                         HTML     90K 
48: R34         Commitments (Tables)                                HTML     70K 
49: R35         Business Segment Information (Tables)               HTML    140K 
50: R36         Business and Summary of Significant Accounting      HTML     54K 
                Policies (Narrative) (Details)                                   
51: R37         Discontinued Operations (Schedule of Condensed      HTML     61K 
                Balance Sheet Aerospace Discontinued Operations)                 
                (Details)                                                        
52: R38         Discontinued Operations (Schedule of Condensed      HTML     82K 
                Statements of Income and Cash Flow of Aerospace                  
                Discontinued Operations) (Details)                               
53: R39         Discontinued Operations (Narrative) (Details)       HTML     53K 
54: R40         Discontinued Operations (Schedule of Condensed      HTML     81K 
                Balance Sheet Financial Freedom Discontinued                     
                Operations) (Details)                                            
55: R41         Discontinued Operations (Schedule of Condensed      HTML     77K 
                Statements of Income and Cash Flow of Financial                  
                Freedom Discontinued Operations) (Details)                       
56: R42         Discontinued Operations (Schedule of Condensed      HTML     63K 
                Combined Balance Sheet of Discontinued Operations)               
                (Details)                                                        
57: R43         Discontinued Operations (Schedule of Condensed      HTML     73K 
                Combined Statements of Income and Cash Flow of                   
                Discontinued Operations) (Details)                               
58: R44         Loans (Schedule of Loans by Product) (Details)      HTML     49K 
59: R45         Loans (Schedule of Loans by Segment, Based on       HTML     50K 
                Obligor Location) (Details)                                      
60: R46         Loans (Components of Net Investment in Loans)       HTML     39K 
                (Details)                                                        
61: R47         Loans (Commercial Loans and Held-For-Sale Loans -   HTML    127K 
                By Risk Rating) (Details)                                        
62: R48         Loans (Narrative) (Details)                         HTML    105K 
63: R49         Loans (Schedule of Consumer Loan LTV                HTML     86K 
                Distributions) (Details)                                         
64: R50         Loans (Loans and Held For Sale Loans - Delinquency  HTML    120K 
                Status) (Details)                                                
65: R51         Loans (Loans on Non-accrual Status) (Details)       HTML     84K 
66: R52         Loans (Schedule of Loans In Process of Foreclosure  HTML     44K 
                and OREO) (Details)                                              
67: R53         Loans (Impaired Loans) (Details)                    HTML     86K 
68: R54         Loans (Purchased Credit Impaired Loans) (Details)   HTML     59K 
69: R55         Loans (Summary of Commercial PCI Loans by Credit    HTML     50K 
                Quality) (Details)                                               
70: R56         Loans (Schedule of Changes to the Accretable Yield  HTML     45K 
                for PCI Loans) (Details)                                         
71: R57         Allowance For Loan Losses (Schedule of Allowance    HTML    102K 
                for Loan Losses and Recorded Investment in Finance               
                Receivables) (Details)                                           
72: R58         Investment Securities (Schedule of Investment       HTML     61K 
                Securities) (Details)                                            
73: R59         Investment Securities (Narrative) (Details)         HTML     69K 
74: R60         Investment Securities (Schedule of Interest and     HTML     43K 
                Dividend Income) (Details)                                       
75: R61         Investment Securities (Amortized Cost and Fair      HTML     72K 
                Value of AFS and HTM Securities) (Details)                       
76: R62         Investment Securities (Schedule of Amortized Cost   HTML    104K 
                and Fair Value Maturities with Changes Recorded in               
                Net Income) (Details)                                            
77: R63         Investment Securities (Schedule of AFS and HTM -    HTML     74K 
                Estimated Unrealized Losses) (Details)                           
78: R64         Investment Securities (Changes in Accretable Yield  HTML     51K 
                for Purchased Credit-Impaired Securities)                        
                (Details)                                                        
79: R65         Borrowings (Schedule of Long-Term Borrowings)       HTML     56K 
                (Details)                                                        
80: R66         Borrowings (Narrative) (Details)                    HTML    149K 
81: R67         Borrowings (Schedule of Senior Unsecured Notes)     HTML     56K 
                (Details)                                                        
82: R68         Borrowings (Schedule of FHLB Advances with Pledged  HTML     38K 
                Assets) (Details)                                                
83: R69         Borrowings (Schedule of Structured Financings and   HTML     55K 
                Pledged Assets) (Details)                                        
84: R70         Borrowings (Assets and Liabilities in               HTML     56K 
                Unconsolidated VIEs) (Details)                                   
85: R71         Derivative Financial Instruments (Fair and          HTML     81K 
                Notional Values of Derivative Financial                          
                Instruments) (Details)                                           
86: R72         Derivative Financial Instruments (Offsetting of     HTML     80K 
                Derivative Assets and Liabilities) (Details)                     
87: R73         Derivative Financial Instruments (Narrative)        HTML     58K 
                (Details)                                                        
88: R74         Derivative Financial Instruments Derivative         HTML     41K 
                Financial Instruments (Fair Value Hedges)                        
                (Details)                                                        
89: R75         Derivative Financial Instruments (Derivative        HTML     55K 
                Instrument Gains and Losses) (Details)                           
90: R76         Derivative Financial Instruments (Changes in AOCI   HTML     48K 
                Relating to Derivatives) (Details)                               
91: R77         Fair Value (Assets and Liabilities Measured at      HTML     85K 
                Fair Value on a Recurring Basis) (Details)                       
92: R78         Fair Value (Narrative) (Details)                    HTML    103K 
93: R79         Fair Value (Quantitative Information about Level 3  HTML     88K 
                Fair Value Measurements-Recurring) (Details)                     
94: R80         Fair Value (Changes in Estimated Fair Value for     HTML     81K 
                Financial Assets and Liabilities Measured on                     
                Recurring Basis) (Details)                                       
95: R81         Fair Value (Carrying Value of Assets Measured at    HTML     69K 
                Fair Value on a Non-Recurring Basis) (Details)                   
96: R82         Fair Value (Carrying and Estimated Fair Values of   HTML    139K 
                Financial Instruments) (Details)                                 
97: R83         Stockholder's Equity (Schedule of Common Stock      HTML     56K 
                Activity) (Details)                                              
98: R84         Stockholders' Equity (Narrative) (Details)          HTML     63K 
99: R85         Stockholders' Equity (Components of Accumulated     HTML     49K 
                Other Comprehensive Income (Loss) ("Aoci"))                      
                (Details)                                                        
100: R86         Stockholders' Equity (Changes in Accumulated Other  HTML     65K  
                Comprehensive Income (Loss) by Component)                        
                (Details)                                                        
101: R87         Stockholders' Equity (Reclassifications out of      HTML     57K  
                AOCI) (Details)                                                  
102: R88         Regulatory Capital (Tier 1 Capital and Total        HTML     78K  
                Capital Components) (Details)                                    
103: R89         Income Taxes (Narrative) (Details)                  HTML     58K  
104: R90         Commitments (Summary of Commitments) (Details)      HTML     73K  
105: R91         Commitments (Narrative) (Details)                   HTML     79K  
106: R92         Contingencies (Narrative) (Details)                 HTML     41K  
107: R93         Business Segment Information (Segment Pre-Tax       HTML    111K  
                Income (Loss)) (Details)                                         
108: R94         Subsequent Events (Details)                         HTML     65K  
109: R9999       Uncategorized Items - cit-20180331.xml              HTML     35K  
111: XML         IDEA XML File -- Filing Summary                      XML    216K  
110: EXCEL       IDEA Workbook of Financial Reports                  XLSX    175K  
 9: EX-101.INS  XBRL Instance -- cit-20180331                        XML   8.82M 
11: EX-101.CAL  XBRL Calculations -- cit-20180331_cal                XML    350K 
12: EX-101.DEF  XBRL Definitions -- cit-20180331_def                 XML   1.78M 
13: EX-101.LAB  XBRL Labels -- cit-20180331_lab                      XML   2.82M 
14: EX-101.PRE  XBRL Presentations -- cit-20180331_pre               XML   2.11M 
10: EX-101.SCH  XBRL Schema -- cit-20180331                          XSD    292K 
112: ZIP         XBRL Zipped Folder -- 0001628280-18-005979-xbrl      Zip    563K

‘EX-101.SCH’ — XBRL Schema — cit-20180331

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cit.com/20180331" xmlns:cit="http://www.cit.com/20180331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">

<xsd:import namespace="http://fasb.org/us-gaap/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-roles/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-roles-2017-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-types/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-types-2017-01-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>

<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/exch/2017-01-31" schemaLocation="http://xbrl.sec.gov/exch/2017/exch-2017-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>

<xsd:annotation>

<xsd:appinfo>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cit-20180331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cit-20180331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cit-20180331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cit-20180331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>

<link:roleType id="AllowanceForLoanLosses" roleURI="http://www.cit.com/role/AllowanceForLoanLosses">

<link:definition> 2104100 - Disclosure - Allowance For Loan Losses </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>